WCLC 2025 - Posters & ePosters-P1.11.35 RATIONALE-303: Long-Term Outcomes With Tislelizumab in Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer

P1.11.35 RATIONALE-303: Long-Term Outcomes With Tislelizumab in Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer

Asset Subtitle

Kirsha Naicker

Meta Tag

Speaker Kirsha Naicker

Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy